Mar 24, 2017
When everyone around you is telling you that you are overworked and on the verge of burnout, it's time to listen, reflect, and take action for your own well-being.
Mar 23, 2017
We may never be able to completely eliminate anxiety and stress before and after scans, yet we can definitely make a difference by confronting scanxiety upfront.
Mar 20, 2017
When the basics of cancer control are not in place, should we discuss targeted agents and immunotherapy in resource-constrained settings?
Subscribe to this column
ASCO Commentary provides an interactive platform for ASCO’s organizational leadership and senior staff to connect directly to ASCO’s membership and the wider oncology community.
Oct 28, 2016
Dr. Richard L. Schilsky outlines the Society's Target Agent and Profiling Utilization Registry (TAPUR) Study and similar international protocols. A global data sharing platform could greatly accelerate our ability to learn about new uses for currently approved targeted anticancer drugs.
Nov 02, 2015
Chief Medical Officer Dr. Richard L. Schilsky answers your questions about this exciting new opportunity in health care policy and advocacy.
Oct 26, 2015
Personalized cancer care is not a new concept, but its application has been enabled and enhanced by a far greater understanding of the biological underpinnings of cancer than ever existed before.
Nov 12, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. During the past six weeks I’ve had the opportunity to attend cancer meetings in four countries on three continents. In September, I represented ASCO at the annual meeting of the Chinese Society of Clinical Oncology (CSCO) in Xiamen,...
Feb 06, 2014
Meaningful Progress Against Gastric, Pancreatic, and Colorectal Cancers Reported at the 2014 Gastrointestinal Cancers Symposium
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. I’ve been a regular attendee of the Gastrointestinal Cancers Symposium since it began 11 years ago. This year’s meeting was among the very best with record attendance, superb educational talks and keynote lectures, multidisciplinary...